Close Menu

T Humes

Initial Experience and Outcomes with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis in the Bahamas

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is an aggressive treatment option for patients with peritoneal carcinomatosis. The procedure is complex but has been proven to be safe and offer survival benefit worldwide and in the Caribbean.


Background: Cytoreductive Surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC) is a treatment option with curative intent for selected patients with peritoneal carcinomatosis (PC). The aim of our study was to report our initial experience with CRS and HIPEC performed by a specialized team in a low volume setting. We set out to determine the safety and efficacy of this treatment and also look at our outcomes with respect to perioperative complications and survival.

26 Oct, 2015
PDF Attachment: 
Journal Sections: 
e-Published: 18 May, 2017


Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Subscribe to RSS - T Humes
Top of Page